Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 1
1996 4
1999 1
2000 2
2002 1
2005 2
2006 3
2007 1
2008 1
2009 4
2011 2
2012 1
2013 1
2015 2
2020 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials.
Sánchez Luna M, Bacher P, Unnebrink K, Martinez-Tristani M, Ramos Navarro C. Sánchez Luna M, et al. J Perinatol. 2020 Aug;40(8):1121-1134. doi: 10.1038/s41372-020-0603-7. Epub 2020 Feb 12. J Perinatol. 2020. PMID: 32051542 Free PMC article. Review.
We extracted study characteristics and outcomes from full-text articles from a systematic search for studies that compared beractant with poractant alfa for RDS in preterm infants. RWE data were tabulated; RCT data were subjected to meta-analyses. ...In RCT meta-analyses, …
We extracted study characteristics and outcomes from full-text articles from a systematic search for studies that compared beractant …
Comparative effectiveness of calfactant and beractant in neonatal respiratory distress syndrome: A systemic review and meta-analysis.
Haider S, Azhar N, Zahid M, Iqbal K, Shoaib N, Irshad N, Siddiqui AS, Ahmed J. Haider S, et al. Pediatr Pulmonol. 2022 Dec;57(12):2928-2936. doi: 10.1002/ppul.26149. Epub 2022 Sep 23. Pediatr Pulmonol. 2022. PMID: 36097672 Review.
Therefore, we conducted a systematic review and meta analysis to compare the effectiveness of two animal extract surfactants (calfactant and beractant) for the management of NRDS. METHODS: We searched Pubmed, Scopus, and Google Scholar for studies comparing efficacy of cal …
Therefore, we conducted a systematic review and meta analysis to compare the effectiveness of two animal extract surfactants (calfactant and …
Less Invasive Surfactant Administration: A Review of Current Evidence of Clinical Outcomes With Beractant.
Sanchez Luna M, Unnebrink K, Martinez-Tristani M, Ramos Navarro C. Sanchez Luna M, et al. Cureus. 2022 Oct 12;14(10):e30223. doi: 10.7759/cureus.30223. eCollection 2022 Oct. Cureus. 2022. PMID: 36381708 Free PMC article. Review.
., 4-5 mL/kg) animal-derived surfactants, the aim of this review was to evaluate and summarize LISA literature for widely used larger-volume beractant. Surfactant treatment and the LISA technique were initially summarized. ...This review provides a detailed assessment of t …
., 4-5 mL/kg) animal-derived surfactants, the aim of this review was to evaluate and summarize LISA literature for widely used larger-volume …
Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis.
Qiu C, Ma C, Fan N, Zhang X, Zheng G. Qiu C, et al. Arch Med Sci. 2020 Jul 11;19(5):1446-1453. doi: 10.5114/aoms.2020.97065. eCollection 2023. Arch Med Sci. 2020. PMID: 37732036 Free PMC article. Review.
The SUCRA (surface under the cumulative ranking) values for each of the drugs were: beractant (8.9%), surfactant A (93.8%), calfactant (40.3%), poractant (65.4%), lucinactant (59.8%), and colfosceril (31.6%). CONCLUSIONS: Compared with beractant, other pulmonary sur …
The SUCRA (surface under the cumulative ranking) values for each of the drugs were: beractant (8.9%), surfactant A (93.8%), calfactan …
Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns - A systematic review.
Moraes LHA, Coelho RMD, Neves Dos Santos Beozzo GP, Yoshida RAM, de Albuquerque Diniz EM, de Carvalho WB. Moraes LHA, et al. J Pediatr (Rio J). 2023 Mar-Apr;99(2):105-111. doi: 10.1016/j.jped.2022.10.007. Epub 2022 Nov 25. J Pediatr (Rio J). 2023. PMID: 36436670 Free PMC article. Review.
The three main studies showed a reduction in the primary outcome; however, all studies showed great heterogeneity regarding the type of surfactant (poractant or beractant) and the method of administration. CONCLUSION: Robust clinical studies, in a heterogeneous population, …
The three main studies showed a reduction in the primary outcome; however, all studies showed great heterogeneity regarding the type of surf …
Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review.
Magni T, Ragni C, Pelizzi N, Sharma S, Perez-Kempner L, Turkstra E, Nathani J, Orlovic M, Meshchenkova N. Magni T, et al. Pharmacoecon Open. 2023 May;7(3):359-371. doi: 10.1007/s41669-023-00399-x. Epub 2023 Mar 11. Pharmacoecon Open. 2023. PMID: 36906631 Free PMC article.
Poractant alfa was found to be cost-effective and cost-saving compared to beractant for the treatment of neonatal RDS in two Russian studies. ...Treatment with poractant alfa was found to be cost-effective versus beractant and cost-saving compared with CPAP alone or …
Poractant alfa was found to be cost-effective and cost-saving compared to beractant for the treatment of neonatal RDS in two Russian …
Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
Singh N, Halliday HL, Stevens TP, Suresh G, Soll R, Rojas-Reyes MX. Singh N, et al. Cochrane Database Syst Rev. 2015 Dec 21;2015(12):CD010249. doi: 10.1002/14651858.CD010249.pub2. Cochrane Database Syst Rev. 2015. PMID: 26690260 Free PMC article. Review.
AUTHORS' CONCLUSIONS: Significant differences in clinical outcome were noted in the comparison trials of modified minced lung surfactant extract (beractant) compared with porcine minced lung surfactant extract (poractant alfa) including a significant increase in the risk o …
AUTHORS' CONCLUSIONS: Significant differences in clinical outcome were noted in the comparison trials of modified minced lung surfactant ext …